SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950137-05-000832
Filing Date
2005-01-28
Accepted
2005-01-28 12:44:41
Documents
5
Period of Report
2005-01-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a05061e8vk.htm 8-K 92972
2 EXHIBIT 1.1 a05061exv1w1.txt EX-1.1 88559
3 EXHIBIT 5.1 a05061exv5w1.htm EX-5.1 7110
4 EXHIBIT 99.1 a05061exv99w1.htm EX-99.1 2536
5 EXHIBIT 99.2 a05061exv99w2.htm EX-99.2 2635
  Complete submission text file 0000950137-05-000832.txt   195936
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 05556973
SIC: 2836 Biological Products, (No Diagnostic Substances)